Tubidy

    CGIC2024 Day 3: Transforming Translational Sciences: From Biomarkers to New Approach Methodologies

    01:03:28•16x

    If you find several Ads windows appear, just Close the Ads and return to this page, then click the "Download" button again, the Download process will start immediately!

    Sorry for showing a lot of ads, we need to make money to pay for the server and keep the tubidy service running smoothly. We apologize for the inconvenience, Your patience is greatly appreciated!

    Download Now

    Download Other Music/Videos

    You Might Also Like

    Who is Critical Path Institute?

    Who is Critical Path Institute?

    Critical Path Institute: 15 Years of Impact

    Critical Path Institute: 15 Years of Impact

    Stephen Coons - How does the PRO Consortium play into C-Path's mission?

    Stephen Coons - How does the PRO Consortium play into C-Path's mission?

    Jane Larkindale - What is C-Path doing that is unique in drug development for rare disease?

    Jane Larkindale - What is C-Path doing that is unique in drug development for rare disease?

    How can a C-Path TRxA grant help academic researchers?

    How can a C-Path TRxA grant help academic researchers?

    Steve Broadbent - Why is C-Path so important in the regulatory science area?

    Steve Broadbent - Why is C-Path so important in the regulatory science area?

    Klaus Romero - What does C-Path do?

    Klaus Romero - What does C-Path do?

    John-Michael Sauer - What makes C-Path so unique?

    John-Michael Sauer - What makes C-Path so unique?

    2nd Workshop on Present and Future Computing Systems | 30th Nov | Afternoon

    2nd Workshop on Present and Future Computing Systems | 30th Nov | Afternoon

    Rick Liwski - What does DCC do with the data contributed to consortia?

    Rick Liwski - What does DCC do with the data contributed to consortia?

    Introduction to C-Path’s International Neonatal Consortium

    Introduction to C-Path’s International Neonatal Consortium

    Martha Brumfield - What is C-Path's purpose and history?

    Martha Brumfield - What is C-Path's purpose and history?

    Klaus Romero - Which diseases have benefited from the development of quantitative solutions?

    Klaus Romero - Which diseases have benefited from the development of quantitative solutions?

    Martha Brumfield - What is a biomarker? How can they improve drug development?

    Martha Brumfield - What is a biomarker? How can they improve drug development?

    Jane Larkindale - Why are C-Path drug development tools important in rare disease drug development?

    Jane Larkindale - Why are C-Path drug development tools important in rare disease drug development?

    John-Michael Sauer - What are biomarkers?

    John-Michael Sauer - What are biomarkers?

    Steve Broadbent - What are biomarkers?

    Steve Broadbent - What are biomarkers?

    A Tribute to Biotech Visionary John Crawford

    A Tribute to Biotech Visionary John Crawford

    Diane Stephenson - How is CPP enhancing clinical trials in Parkinson's disease?

    Diane Stephenson - How is CPP enhancing clinical trials in Parkinson's disease?

    Introduction to Jagdeep Podichetty, Director of Predictive Analytics, Quantitative Medicine

    Introduction to Jagdeep Podichetty, Director of Predictive Analytics, Quantitative Medicine